山河药辅（300452.SZ）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他55.59%
个人与内部人士30.15%
私营企业8.30%
机构投资者5.95%

主要股东

主要股东最新
股东
Changhong Wu	20.33%	4,729.31 万	<0.01%	+0	2026/03/31
Shanghai Fosun Pharmaceutical Development Co., Ltd.	8.30%	1,931.96 万	0.82%	-191.40 万	2026/03/31
Zhiya Yin	6.78%	1,576.44 万	<0.01%	+0	2026/03/31
Bank of China Investment Management Co., Ltd.	1.40%	324.99 万	0.34%	+78.00 万	2026/03/31
Tao LiuFormer Director	1.33%	309.11 万	0.36%	-82.99 万	2026/03/31
Broad Asset Management Co., Ltd	1.15%	266.75 万	<0.01%	+0	2025/12/31
The Goldman Sachs Group, Inc.	0.69%	160.55 万	--	+160.55 万	2026/03/31
GF Securities Asset Management Co.,Ltd.	0.61%	141.69 万	<0.01%	+0	2025/12/31
Invesco Great Wall Fund Management Co. Ltd	0.52%	120.83 万	0.06%	+14.37 万	2026/03/31
UBS Asset Management AG	0.49%	113.53 万	0.24%	-55.96 万	2026/03/31
Tang Dong ZhuFormer Chairman of Supervisory Board	0.41%	95.95 万	<0.01%	+0	2025/03/31
Yu Cheng Tian	0.39%	90.00 万	<0.01%	+0	2025/06/30
Wei YuFormer Chief Engineer	0.37%	86.00 万	<0.01%	+0	2025/06/30
Li Li	0.35%	81.88 万	0.00%	+0	2025/12/31
Nanhua Fund Management Co., Ltd.	0.33%	76.38 万	<0.01%	+0	2025/12/31
Gfund Management Co., Ltd.	0.25%	58.73 万	0.00%	+0	2025/12/31
Huatai-PineBridge Fund Management Co., Ltd.	0.21%	49.80 万	0.00%	+0	2025/12/31
China Fund Management Co., Ltd.	0.20%	45.66 万	0.00%	+0	2025/06/30
Dao Cai SongGM & Non-Independent Director	0.09%	21.09 万	0.00%	+0	2025/12/31
Zi Hu Liu	0.04%	9.27 万	<0.01%	+0	2025/12/31